Tsimikas S - Search Results

1

Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.

Vuorio A, Watts GF, Schneider WJ, Tsimikas S, Kovanen PT. Vuorio A, et al. Among authors: tsimikas s. J Intern Med. 2020 Jan;287(1):2-18. doi: 10.1111/joim.12981. J Intern Med. 2020. PMID: 31858669 Free article. Review.

2

Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.

Rodenburg J, Vissers MN, Wiegman A, Miller ER, Ridker PM, Witztum JL, Kastelein JJ, Tsimikas S. Rodenburg J, et al. Among authors: tsimikas s. J Am Coll Cardiol. 2006 May 2;47(9):1803-10. doi: 10.1016/j.jacc.2005.12.047. Epub 2006 Apr 17. J Am Coll Cardiol. 2006. PMID: 16682304 Free article. Clinical Trial.

3

Emerging therapeutic agents to lower lipoprotein (a) levels.

Kolski B, Tsimikas S. Kolski B, et al. Among authors: tsimikas s. Curr Opin Lipidol. 2012 Dec;23(6):560-8. doi: 10.1097/MOL.0b013e3283598d81. Curr Opin Lipidol. 2012. PMID: 23041907 Review.

4

Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.

Santos RD, Raal FJ, Catapano AL, Witztum JL, Steinhagen-Thiessen E, Tsimikas S. Santos RD, et al. Among authors: tsimikas s. Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):689-99. doi: 10.1161/ATVBAHA.114.304549. Epub 2015 Jan 22. Arterioscler Thromb Vasc Biol. 2015. PMID: 25614280 Free PMC article.

5

'LDL-C' = LDL-C + Lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin/kexin type 9 era of potent LDL-C lowering.

Yeang C, Witztum JL, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. Curr Opin Lipidol. 2015 Jun;26(3):169-78. doi: 10.1097/MOL.0000000000000171. Curr Opin Lipidol. 2015. PMID: 25943842 Review.

6

Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.

Yeang C, Cotter B, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. Cardiovasc Drugs Ther. 2016 Feb;30(1):75-85. doi: 10.1007/s10557-015-6634-1. Cardiovasc Drugs Ther. 2016. PMID: 26780907 Review.

7

Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk.

Tsimikas S. Tsimikas S. Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):157-64. doi: 10.1097/MED.0000000000000237. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26825471 Free PMC article. Review.

8

PCSK9 Association With Lipoprotein(a).

Tavori H, Christian D, Minnier J, Plubell D, Shapiro MD, Yeang C, Giunzioni I, Croyal M, Duell PB, Lambert G, Tsimikas S, Fazio S. Tavori H, et al. Among authors: tsimikas s. Circ Res. 2016 Jun 24;119(1):29-35. doi: 10.1161/CIRCRESAHA.116.308811. Epub 2016 Apr 27. Circ Res. 2016. PMID: 27121620 Free PMC article.

9

Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.

Yeang C, Wilkinson MJ, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. Curr Opin Cardiol. 2016 Jul;31(4):440-50. doi: 10.1097/HCO.0000000000000300. Curr Opin Cardiol. 2016. PMID: 27205885 Free PMC article. Review.

10

Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).

Yeang C, Hung MY, Byun YS, Clopton P, Yang X, Witztum JL, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. J Clin Lipidol. 2016 May-Jun;10(3):594-603. doi: 10.1016/j.jacl.2016.01.005. Epub 2016 Mar 8. J Clin Lipidol. 2016. PMID: 27206947 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page